$ZIOP News Article - Ziopharm Oncology Announces Publication of Positive Results of Phase 1 Monotherapy Trial of Controlled IL-12 in Patients with Recurrent Glioblastoma in Science Translational Medicine
https://marketwirenews.com/news-releases/ziop...29759.html